Finally, the probe can specifically label CTGF in brain sections of AD patients and detect CTGF by fluorescence imaging, ICP-MS quantification, and peroxidase-like catalyzed chromogenic imaging, which further demonstrated its potential in earlier AD diagnosis. The gene discussed is CCN2; the disease is Alzheimer disease.